Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Leaseir MHR Xcell

K-Number: K214049 · 2022-06-02

Decision Date2022-06-02
Product CodeGEX
Advisory CommitteeSU
DecisionSubstantially Equivalent

Device Summary

Leaseir MHR Xcell is a medical device manufactured by Leaseir Technologies, Slu. It received FDA 510(k) clearance on 2022-06-02 under approval number K214049. The device is classified under product code GEX. It was reviewed by the SU advisory panel. Product code GEX falls under the category of Gastroenterology, which includes gastrointestinal diagnostic and therapeutic devices. Devices in this category are subject to specific FDA regulatory requirements. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Leaseir MHR Xcell?

Leaseir MHR Xcell is a medical device that received FDA 510(k) clearance on 2022-06-02. It is manufactured by Leaseir Technologies, Slu. The 510(k) number is K214049.

When was Leaseir MHR Xcell approved by the FDA?

Leaseir MHR Xcell received FDA 510(k) clearance on 2022-06-02, under approval number K214049.

What company makes Leaseir MHR Xcell?

Leaseir MHR Xcell is manufactured by Leaseir Technologies, Slu.

What is the FDA product code for Leaseir MHR Xcell?

The FDA product code for Leaseir MHR Xcell is GEX. This falls under the Gastroenterology category.

Other Devices by Leaseir Technologies, Slu

Related Devices (Code: GEX)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.